163 related articles for article (PubMed ID: 26622499)
1. Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.
He W; Sun Z; Liu Z
Exp Ther Med; 2015 Oct; 10(4):1413-1418. PubMed ID: 26622499
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
[TBL] [Abstract][Full Text] [Related]
3. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
4. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.
Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J
BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056
[TBL] [Abstract][Full Text] [Related]
5. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
6. The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
Seo S; Moon Y; Choi J; Yoon S; Jung KH; Cheon J; Kim W; Kim D; Lee CH; Kim SW; Park KS; Lee DH
Am J Cancer Res; 2019; 9(3):597-607. PubMed ID: 30949413
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1297 downregulation inhibits breast cancer cell epithelial-mesenchymal transition and proliferation in a FA2H-dependent manner.
Li H; Lian B; Liu Y; Chai D; Li J
Oncol Lett; 2020 Dec; 20(6):277. PubMed ID: 33014155
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
9. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
11. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression.
Lee HH; Jung J; Moon A; Kang H; Cho H
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252615
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
13. [Effects of FBI-1 silencing on proliferation and apoptosis of triple-negative breast cancer cell line MDA-MB-231].
Chen MJ; Wang L; Yang WP; Qin QH; Tan QX; Lian B; Wei CY
Sheng Li Xue Bao; 2018 Oct; 70(5):497-503. PubMed ID: 30377688
[TBL] [Abstract][Full Text] [Related]
14. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
[TBL] [Abstract][Full Text] [Related]
15. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
16. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Ai L; Kim WJ; Demircan B; Dyer LM; Bray KJ; Skehan RR; Massoll NA; Brown KD
Carcinogenesis; 2008 Mar; 29(3):510-8. PubMed ID: 18174247
[TBL] [Abstract][Full Text] [Related]
17. Expression of P2X7R in breast cancer tissue and the induction of apoptosis by the gene-specific shRNA in MCF-7 cells.
Tan C; Han LI; Zou L; Luo C; Liu A; Sheng X; Xi D
Exp Ther Med; 2015 Oct; 10(4):1472-1478. PubMed ID: 26622509
[TBL] [Abstract][Full Text] [Related]
18. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
19. The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2.
Bianchi N; Brugnoli F; Grassilli S; Bourgeois K; Keillor JW; Bergamini CM; Aguiari G; Volinia S; Bertagnolo V
Cells; 2021 Nov; 10(11):. PubMed ID: 34831282
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
Agnihotri N; Kumar S; Mehta K
Breast Cancer Res; 2013 Feb; 15(1):202. PubMed ID: 23673317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
